Clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer, is increasingly understood as a malignancy shaped by profound changes in cellular metabolism. A comprehensive review published in Genes & Diseases highlights how these metabolic alterations contribute to tumour growth, immune evasion and treatment resistance, while revealing potential opportunities for new therapeutic approaches.

A review published in Genes & Diseases highlights the complex interplay between protein arginine methylation and ubiquitination, two forms of protein modification that can profoundly influence cancer development, progression and treatment response. The article brings together current understanding of how these interconnected molecular processes regulate proteins involved in cancer and identifies opportunities for future therapeutic approaches.

Triple-negative breast cancer (TNBC) remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment in other breast cancer subtypes. A review published in Genes & Diseases examines how targeting the epidermal growth factor receptor (EGFR) alongside other molecular targets, supported by nanocarrier-based delivery, could offer new possibilities for more precise TNBC treatment.

MIT researchers developed a handheld device that can gently collect living cells from specific locations to test for ovarian and other cancers. The technique could be used to catch cancers earlier and more effectively, and to create personalized treatments.

Explore a shared vulnerability in two of the childhood brain tumor’s types, opening opportunities for targeted therapies in patients with high-risk disease.

Two members of NCCN’s Global Policy team are presenting original research abstracts on National Cancer Control Plans and Tailoring Guidelines for Regional Realities as part of the three-day World Cancer Congress in Hong Kong.